It was considered that high levels of adiponectin should benefit the health of people with CKD, which has been confirmed in many studies where lower adiponectin levels were associated with a higher incidence of cardiovascular events [106,107,108]. This evidence concerns the gene ADIPOQ and chronic kidney disease.